{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:08:18Z","timestamp":1793830098339,"version":"4.6.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005851","name":"shahid Beheshti University of Medical Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12876-019-1055-4","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T13:02:33Z","timestamp":1564059753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":154,"title":["Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial"],"prefix":"10.1186","volume":"19","author":[{"given":"Saeede","family":"Saadati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asieh","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Yari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Poustchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Hedayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Hatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1944-0052","authenticated-orcid":false,"given":"Azita","family":"Hekmatdoost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,25]]},"reference":[{"issue":"2","key":"1055_CR1","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3945\/an.116.013151","volume":"8","author":"Z Mokhtari","year":"2017","unstructured":"Mokhtari Z, Gibson DL, Hekmatdoost A. Nonalcoholic fatty liver disease, the gut microbiome, and diet. Adv Nutr. 2017;8(2):240\u201352.","journal-title":"Adv Nutr"},{"issue":"3","key":"1055_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease\u2014a global public health perspective. J Hepatol. 2019;70(3):531\u201344.","journal-title":"J Hepatol"},{"issue":"3","key":"1055_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3945\/ajcn.113.068890","volume":"99","author":"T Eslamparast","year":"2014","unstructured":"Eslamparast T, et al. Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. Am J Clin Nutr. 2014;99(3):535\u201342.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"1055_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12876-018-0906-8","volume":"18","author":"FG Foschi","year":"2018","unstructured":"Foschi FG, et al. Prevalence of and risk factors for fatty liver in the general population of northern Italy: the Bagnacavallo study. BMC Gastroenterol. 2018;18(1):177.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"1055_CR5","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1):S47\u201364.","journal-title":"J Hepatol"},{"issue":"8","key":"1055_CR6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65(8):1038\u201348.","journal-title":"Metabolism"},{"key":"1055_CR7","first-page":"9","volume":"18","author":"M Darand","year":"2018","unstructured":"Darand M, Alavian SM, Hekmatdoost A. Nigella sativa and non-alcoholic fatty liver disease: a review of the current evidence. Hepat Mon. 2018;18:9.","journal-title":"Hepat Mon"},{"key":"1055_CR8","doi-asserted-by":"crossref","unstructured":"Ghaemi A, et al. How much weight loss is effective on nonalcoholic fatty liver disease? Hepat Mon. 2013;13(12).","DOI":"10.5812\/hepatmon.15227"},{"key":"1055_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40200-016-0248-4","volume":"15","author":"H Emamat","year":"2015","unstructured":"Emamat H, et al. The effects of onion consumption on treatment of metabolic, histologic, and inflammatory features of nonalcoholic fatty liver disease. J Diabetes Metab Disord. 2015;15:25.","journal-title":"J Diabetes Metab Disord"},{"issue":"8","key":"1055_CR10","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1080\/09637486.2016.1210101","volume":"67","author":"A Hekmatdoost","year":"2016","unstructured":"Hekmatdoost A, et al. Adherence to the dietary approaches to stop hypertension (DASH) and risk of nonalcoholic fatty liver disease. Int J Food Sci Nutr. 2016;67(8):1024\u20139.","journal-title":"Int J Food Sci Nutr"},{"issue":"10","key":"1055_CR11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.4254\/wjh.v9.i10.503","volume":"9","author":"Z Mokhtari","year":"2017","unstructured":"Mokhtari Z, et al. Egg consumption and risk of non-alcoholic fatty liver disease. World J Hepatol. 2017;9(10):503\u20139.","journal-title":"World J Hepatol"},{"issue":"8","key":"1055_CR12","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1002\/jsfa.8042","volume":"97","author":"M Noori","year":"2017","unstructured":"Noori M, Jafari B, Hekmatdoost A. Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation. J Sci Food Agric. 2017;97(8):2327\u201332.","journal-title":"J Sci Food Agric"},{"issue":"25","key":"1055_CR13","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.4254\/wjh.v7.i25.2597","volume":"7","author":"M Rahimlou","year":"2015","unstructured":"Rahimlou M, Ahmadnia H, Hekmatdoost A. Dietary supplements and pediatric non-alcoholic fatty liver disease: present and the future. World J Hepatol. 2015;7(25):2597\u2013602.","journal-title":"World J Hepatol"},{"issue":"1","key":"1055_CR14","doi-asserted-by":"publisher","first-page":"e34897","DOI":"10.5812\/hepatmon.34897","volume":"16","author":"M Rahimlou","year":"2016","unstructured":"Rahimlou M, et al. Ginger supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. Hepat Mon. 2016;16(1):e34897.","journal-title":"Hepat Mon"},{"issue":"2","key":"1055_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3109\/19390211.2015.1008611","volume":"13","author":"Y Panahi","year":"2016","unstructured":"Panahi Y, et al. Mitigation of systemic oxidative stress by Curcuminoids in osteoarthritis: results of a randomized controlled trial. J Diet Suppl. 2016;13(2):209\u201320.","journal-title":"J Diet Suppl"},{"issue":"12","key":"1055_CR16","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1177\/0748233713491807","volume":"31","author":"AA Alm-Eldeen","year":"2015","unstructured":"Alm-Eldeen AA, et al. Synergistic effect of black tea and curcumin in improving the hepatotoxicity induced by aflatoxin B1 in rats. Toxicol Ind Health. 2015;31(12):1269\u201380.","journal-title":"Toxicol Ind Health"},{"issue":"2","key":"1055_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.etap.2010.04.001","volume":"30","author":"J Dattani","year":"2010","unstructured":"Dattani J, et al. Ameliorative effect of curcumin on hepatotoxicity induced by chloroquine phosphate. Environ Toxicol Pharmacol. 2010;30(2):103\u20139.","journal-title":"Environ Toxicol Pharmacol"},{"issue":"8","key":"1055_CR18","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/mnfr.201100818","volume":"56","author":"D Coban","year":"2012","unstructured":"Coban D, et al. Dietary curcumin inhibits atherosclerosis by affecting the expression of genes involved in leukocyte adhesion and transendothelial migration. Mol Nutr Food Res. 2012;56(8):1270\u201381.","journal-title":"Mol Nutr Food Res"},{"issue":"6","key":"1055_CR19","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jhep.2004.08.010","volume":"41","author":"IA Leclercq","year":"2004","unstructured":"Leclercq IA, et al. Curcumin inhibits NF-\u03baB activation and reduces the severity of experimental steatohepatitis in mice. J Hepatol. 2004;41(6):926\u201334.","journal-title":"J Hepatol"},{"issue":"9","key":"1055_CR20","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/ptr.5659","volume":"30","author":"S Rahmani","year":"2016","unstructured":"Rahmani S, et al. Treatment of non-alcoholic fatty liver disease with curcumin: a randomized placebo-controlled trial. Phytother Res. 2016;30(9):1540\u20138.","journal-title":"Phytother Res"},{"issue":"7","key":"1055_CR21","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1002\/mnfr.201501034","volume":"60","author":"A Kocher","year":"2016","unstructured":"Kocher A, et al. Highly bioavailable micellar curcuminoids accumulate in blood, are safe and do not reduce blood lipids and inflammation markers in moderately hyperlipidemic individuals. Mol Nutr Food Res. 2016;60(7):1555\u201363.","journal-title":"Mol Nutr Food Res"},{"key":"1055_CR22","unstructured":"Parizadeh S.M., M. Ghayour-Mobarhan, ScientificWorldJournal."},{"key":"1055_CR23","unstructured":"NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults (US). Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda: National Heart, Lung, and Blood Institute; 1998 Sep. Available from: \n                              https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK2003\/\n                              \n                           ."},{"issue":"3","key":"1055_CR24","first-page":"157","volume":"11","author":"R Malekzadeh","year":"2011","unstructured":"Malekzadeh R, Poustchi H. Fibroscan for assessing liver fibrosis: an acceptable alternative for liver biopsy: Fibroscan: an acceptable alternative for liver biopsy. Hepat Mon. 2011;11(3):157.","journal-title":"Hepat Mon"},{"issue":"9; SUPP\/1","key":"1055_CR25","doi-asserted-by":"publisher","first-page":"S498","DOI":"10.1097\/00005768-200009001-00009","volume":"32","author":"BE Ainsworth","year":"2000","unstructured":"Ainsworth BE, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32(9; SUPP\/1):S498\u2013504.","journal-title":"Med Sci Sports Exerc"},{"key":"1055_CR26","first-page":"213","volume-title":"The manual for household measures, cooking yields factors and edible portion of foods","author":"M Ghaffarpour","year":"1999","unstructured":"Ghaffarpour M, Houshiar-Rad A, Kianfar H. The manual for household measures, cooking yields factors and edible portion of foods, vol. 7. Tehran: Nashre Olume Keshavarzy; 1999. p. 213."},{"issue":"2","key":"1055_CR27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1139\/cjpp-2016-0152","volume":"95","author":"ME Kelany","year":"2016","unstructured":"Kelany ME, Hakami TM, Omar AH. Curcumin improves the metabolic syndrome in high-fructose-diet-fed rats: role of TNF-\u03b1, NF-\u03baB, and oxidative stress. Can J Physiol Pharmacol. 2016;95(2):140\u201350.","journal-title":"Can J Physiol Pharmacol"},{"key":"1055_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cbi.2015.12.012","volume":"244","author":"N Maithilikarpagaselvi","year":"2016","unstructured":"Maithilikarpagaselvi N, et al. Curcumin prevents inflammatory response, oxidative stress and insulin resistance in high fructose fed male Wistar rats: potential role of serine kinases. Chem Biol Interact. 2016;244:187\u201394.","journal-title":"Chem Biol Interact"},{"issue":"7","key":"1055_CR29","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.freeradbiomed.2009.06.015","volume":"47","author":"MC Ramirez-Tortosa","year":"2009","unstructured":"Ramirez-Tortosa MC, et al. Curcumin ameliorates rabbits's steatohepatitis via respiratory chain, oxidative stress, and TNF-\u03b1. Free Radic Biol Med. 2009;47(7):924\u201331.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"1055_CR30","first-page":"469","volume":"19","author":"J-W Cho","year":"2007","unstructured":"Cho J-W, Lee K-S, Kim C-W. Curcumin attenuates the expression of IL-1\u03b2, IL-6, and TNF-\u03b1 as well as cyclin E in TNF-\u03b1-treated HaCaT cells; NF-\u03baB and MAPKs as potential upstream targets. Int J Mol Med. 2007;19(3):469\u201374.","journal-title":"Int J Mol Med"},{"issue":"3","key":"1055_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00394-011-0188-1","volume":"50","author":"A Shehzad","year":"2011","unstructured":"Shehzad A, et al. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. Eur J Nutr. 2011;50(3):151\u201361.","journal-title":"Eur J Nutr"},{"issue":"7","key":"1055_CR32","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1161\/hc0702.104279","volume":"105","author":"P Ziccardi","year":"2002","unstructured":"Ziccardi P, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation. 2002;105(7):804\u20139.","journal-title":"Circulation"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-019-1055-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-019-1055-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-019-1055-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T23:13:06Z","timestamp":1595545986000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-019-1055-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1055"],"URL":"https:\/\/doi.org\/10.1186\/s12876-019-1055-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,25]]},"assertion":[{"value":"7 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants provided their written informed consent to participate in this study. The study protocol was approved by Ethics Committee of National Nutrition and Food Technology Research Institute at Shahid Beheshti University of Medical Sciences (IR.SBMU.nnftri.Rec.1395.106).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare to have no financial and non-financial competing interests related to this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}